نتایج جستجو برای: antidepressant

تعداد نتایج: 13691  

2017
Hao Liu Zhi-Min Yang Ying Geng Huan Yang De-Heng Zhao Wei-Dong Xiao Gao-Hua Wang

OBJECTIVE The study aims to help domestic application units and research institutions improve their research quality of antidepressant clinical tests by studying and analyzing the current status and problems in selecting control drugs during domestic antidepressant clinical tests and illustrating some key problems that should be noted when selecting the control drug in such researches. METHOD...

2016
Hongkun Bao Pengzhan Ran Ming Zhu Lijuan Sun Bai Li Yangyang Hou Jun Nie Liping Shan Hongliang Li Shangyong Zheng Xiufeng Xu Chunjie Xiao Jing Du

Proteo-β-glucan from Maitake (PGM) is a strong immune regulator, and its receptor is called Dectin-1. Cumulative evidence suggests that AMPA receptors are important for the treatment of depression. Here, we report that PGM treatment leads to a significant antidepressant effect in the tail suspension test and forced swim test after sixty minutes of treatment in mice. After five consecutive days ...

Journal: :The Journal of clinical psychiatry 2007
Christine J Truman Joseph F Goldberg S Nassir Ghaemi Claudia F Baldassano Stephen R Wisniewski Ellen B Dennehy Michael E Thase Gary S Sachs

OBJECTIVE Antidepressant safety and efficacy remain controversial for the treatment of bipolar depression. The present study utilized data from the National Institute of Mental Health Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) to examine the prevalence and clinical correlates of self-reported switch into mania/hypomania during antidepressant treatment. METHOD Anti...

Journal: :Biological Psychiatry 2018
Chun Yang Qian Ren Youge Qu Ji-Chun Zhang Min Ma Chao Dong Kenji Hashimoto

BACKGROUND The role of the mechanistic target of rapamycin (mTOR) signaling in the antidepressant effects of ketamine is controversial. In addition to mTOR, extracellular signal-regulated kinase (ERK) is a key signaling molecule in prominent pathways that regulate protein synthesis. (R)-Ketamine has a greater potency and longer-lasting antidepressant effects than (S)-ketamine. Here we investiga...

2011
Mika Kivimäki G. David Batty Markus Jokela Klaus P. Ebmeier Jussi Vahtera Marianna Virtanen Eric J. Brunner Adam G. Tabak Daniel R. Witte Meena Kumari Archana Singh-Manoux Mark Hamer

BACKGROUND Previous research suggests a link between antidepressant use and diabetes, but it is unclear whether the association is causal or attributable to detection/ascertainment bias. To examine this, we assessed the associations of antidepressant use with change in glucose levels and incidence of undiagnosed and diagnosed diabetes. METHODS During an 18-year period, we monitored antidepres...

2014
Tammy SAAH Steven J. GARLOW Mark H. RAPAPORT

Many patients with chronic or recurring major depressive disorder have suboptimal responses to the wide range of antidepressant medications available. When confronted with these patients, clinicians may augment the original antidepressant with other medications, including adjunctive treatment with a second or third antidepressant. Although it is a widely-used practice among psychiatrists and pr...

Journal: :Psychiatry research 2015
Somaia Mohamed Gary R Johnson Julia E Vertrees Peter D Guarino Kimberly Weingart Ilanit Tal Young Jean Yoon Theresa C Gleason Katherine A Kirkwood Amy M Kilbourne Martha Gerrity Stephen Marder Kousick Biswas Paul Hicks Lori L Davis Peijun Chen AlexandraMary Kelada Grant D Huang David D Lawrence Mary LeGwin Sidney Zisook

Because two-thirds of patients with Major Depressive Disorder do not achieve remission with their first antidepressant, we designed a trial of three "next-step" strategies: switching to another antidepressant (bupropion-SR) or augmenting the current antidepressant with either another antidepressant (bupropion-SR) or with an atypical antipsychotic (aripiprazole). The study will compare 12-week r...

Journal: :Journal of psychiatry & neuroscience : JPN 2017
Lily R Aleksandrova Anthony G Phillips Yu Tian Wang

The molecular mechanisms underlying major depressive disorder remain poorly understood, and current antidepressant treatments have many shortcomings. The recent discovery that a single intravenous infusion of ketamine at a subanesthetic dose had robust, rapid and sustained antidepressant effects in individuals with treatment-resistant depression inspired tremendous interest in investigating the...

Journal: :The Journal of clinical psychiatry 2014
Chittaranjan Andrade

Antidepressant augmentation strategies are commonly employed to treat depressed patients who do not respond to antidepressant monotherapy. Neuroinflammatory mechanisms have been implicated in depression, and nonsteroidal anti-inflammatory drugs (NSAIDs) have been found effective in animal models of depression both in monotherapy and when used to augment antidepressant drugs. However, results wi...

Journal: :Pharmacological reports : PR 2005
Gabriel Nowak Bernadeta Szewczyk Andrzej Pilc

Unsatisfactory clinical efficacy and a variety of adverse effects of current antidepressant drugs have incited search for better therapy. Zinc, an antagonist of the glutamate/N-methyl-D-aspartate (NMDA) receptor, exhibits antidepressant-like activity in rodent tests/models of depression. Similarly to antidepressants, zinc induces brain derived neurotrophic factor (BDNF) gene expression and incr...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید